- Previous Close
2,000.40 - Open
1,992.40 - Bid 1,978.30 x --
- Ask 1,982.70 x --
- Day's Range
1,978.25 - 2,011.95 - 52 Week Range
1,450.05 - 2,306.85 - Volume
1,647 - Avg. Volume
4,029 - Market Cap (intraday)
101.458B - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
68.88 - EPS (TTM)
28.73 - Earnings Date Jan 31, 2025 - Feb 4, 2025
- Forward Dividend & Yield 4.00 (0.20%)
- Ex-Dividend Date Nov 17, 2023
- 1y Target Est
2,170.53
Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.
www.metropolisindia.com4,313
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: METROPOLIS.BO
View MorePerformance Overview: METROPOLIS.BO
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: METROPOLIS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: METROPOLIS.BO
View MoreValuation Measures
Market Cap
103.71B
Enterprise Value
103.70B
Trailing P/E
70.31
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.10
Price/Book (mrq)
8.76
Enterprise Value/Revenue
8.07
Enterprise Value/EBITDA
32.01
Financial Highlights
Profitability and Income Statement
Profit Margin
11.52%
Return on Assets (ttm)
8.63%
Return on Equity (ttm)
13.29%
Revenue (ttm)
12.85B
Net Income Avi to Common (ttm)
1.48B
Diluted EPS (ttm)
28.73
Balance Sheet and Cash Flow
Total Cash (mrq)
1.85B
Total Debt/Equity (mrq)
15.96%
Levered Free Cash Flow (ttm)
1.82B